Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 61.50
+0.70 (1.15%)
Aug 27, 2026, 5:35 PM CET
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €3.11 billion as of August 27, 2026. Its market cap has increased by 6.28% in one year.
Market Cap
3.11B
Enterprise Value
3.11B
Revenue
773.05M
Ranking
n/a
PE Ratio
16.79
Stock Price
€61.50
ChartMarket Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 356.09K to 3.11B, an increase of 873,132.69%. That is a compound annual growth rate of 62.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 3.11B | -4.26% |
| Dec 31, 2025 | 3.25B | 0.87% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.03B |
| Almirall | 2.24B |
| Pharma Mar | 1.43B |
| Faes Farma | 1.40B |
| Clínica Baviera | 942.75M |
| Oryzon Genomics | 232.45M |
| Prim, S.A. | 227.06M |
| Laboratorio Reig Jofre | 217.37M |